SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-15-065553
Filing Date
2015-09-16
Accepted
2015-09-16 16:35:39
Documents
8
Period of Report
2015-09-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a15-19283_48k.htm 8-K 40771
2 EX-1.1 a15-19283_4ex1d1.htm EX-1.1 322211
3 EX-5.1 a15-19283_4ex5d1.htm EX-5.1 12150
4 EX-99.1 a15-19283_4ex99d1.htm EX-99.1 10747
5 EX-99.2 a15-19283_4ex99d2.htm EX-99.2 11660
6 GRAPHIC g192834mai001.jpg GRAPHIC 4837
7 GRAPHIC g192834mci001.jpg GRAPHIC 4837
8 GRAPHIC g192834kgi001.jpg GRAPHIC 2008
  Complete submission text file 0001104659-15-065553.txt   415193
Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Filer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35921 | Film No.: 151110615
SIC: 2834 Pharmaceutical Preparations